News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
152 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (8)
2 (146)
3 (83)
4 (7)
5 (215)
6 (50)
7 (4)
8 (8)
9 (162)
10 (176)
11 (140)
12 (138)
13 (79)
14 (3)
15 (2)
16 (148)
17 (198)
18 (151)
19 (189)
20 (83)
21 (5)
22 (6)
23 (133)
24 (183)
25 (184)
26 (185)
27 (83)
28 (1)
29 (3)
30 (152)
31 (162)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Biotech Bay
ITUS Corporation Releases Results for Cchek™ Breast Cancer Study
Cchek™ is a non-invasive (utilizing a blood sample), artificial intelligence (AI) guided, liquid biopsy cancer detection platform
July 30, 2018
·
3 min read
Pharm Country
OTC Markets Group Welcomes Phivida to OTCQX
Phivida upgraded to OTCQX from the Pink® market.
July 30, 2018
·
2 min read
Genetown
IFM Therapeutics Announces New Publication in Nature Reviews Drug Discovery Examining NLRP3 as a Target in Serious Inflammatory and Immune-Mediated Diseases
Comprehensive review surveys the potential therapeutic role of NLRP3 inhibition across a range of common diseases with unmet medical need
July 30, 2018
·
3 min read
Business
Enzyvant Expands Leadership Team with Appointments of Andrew Dawson and Alex Tracy
Enzyvant is a biopharmaceutical company focused on developing innovative therapies for patients with rare diseases.
July 30, 2018
·
2 min read
Pharm Country
Henry Schein Donates 4,000 Welcome Kits To Guests Staying At American Cancer Society Hope Lodge Facilities
Company Marks 10 Years of Providing Personal Hygiene Products and Related Items for People Fighting Cancer Far from Home
July 30, 2018
·
4 min read
Business
HiFiBiO Therapeutics Signs Multi-Target Antibody Discovery Agreement with Takeda
Global pharmaceutical leader selects innovative single-B-cell technology to generate breakthrough therapies
July 30, 2018
·
2 min read
Business
Rockwell Medical Announces Engagement of Marcum LLP as New Independent Auditor
Rockwell Medical, Inc. announced that the Audit Committee of its Board of Directors has engaged Marcum LLP as Rockwell Medical’s new independent registered public accounting firm.
July 30, 2018
·
3 min read
Business
Emmaus Life Sciences Partners with DMS Pharmaceutical Group to Provide Endari™ (L-glutamine oral powder) to Military Personnel and Beneficiaries for Treatment of Sickle Cell Disease
Emmaus Life Sciences (Emmaus) announces it has entered into a distribution agreement with DMS Pharmaceutical Group (DMS).
July 30, 2018
·
4 min read
Business
Tenaya Therapeutics Appoints Faraz Ali as Chief Executive Officer
Tenaya Therapeutics is a preclinical-stage biotechnology company focused on discovery and development of novel therapies for heart failure
July 30, 2018
·
3 min read
FDA
Nektar Therapeutics Announces New Drug Application for NKTR-181 Accepted for Review by FDA
NKTR-181 is a First-in-Class Investigational Opioid to Treat Chronic Low Back Pain in Adult Patients New to Opioid Therapy
July 30, 2018
·
6 min read
Previous
3 of 16
Next